cancer of unknown primary
AI-Based Pathology Method Developed to Potentially Uncover Cancers of Unknown Primary Origin
Premium
In a paper published in Nature, Brigham and Women's researchers describe a novel computational pathology method to improve diagnosis and treatment of metastatic cancers.
Cancer Dx Firm C2i Genomics Raises $100M in Financing
The company will use the funds to accelerate the clinical development and commercialization of its minimal residual disease detection C2-Intelligence Platform.
Caris Shares Data for AI-Driven Tumor Origin Prediction, Hinting at Diagnostic, Patient Benefit
Premium
Investigators reported that the classifier could correctly predict cancer type with over 94 percent accuracy and highlighted impacts in a commercially tested cohort.
Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition
The new consortium is aiming to make comprehensive genomic profiling accessible to advanced cancer patients in the US, to help inform their treatment decisions.
Microbiome-Based Cancer Dx Emerges From Cancer Genome Atlas Reanalysis
Researchers re-examined whole-genome and whole-transcriptome sequencing TCGA studies from 33 cancer types and found unique microbial signatures.